Universidad Carlos III de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors

    Molecular Therapy - Methods and Clinical Development, Vol. 27, pp. 96-108